Ranbaxy Laboratories Launches Generic Atorvastatin in European Markets
Published: Mar 06, 2012
Ranbaxy Laboratories Ltd. announced the launch of a generic version of Atorvastatin tablets in 10mg, 20mg, 40mg and 80 mg in Italy and Sweden and 10mg, 20mg and 40mg in the Netherlands. It introduced the product ahead of the applicable patent expiry in accordance with a settlement agreed with Pfizer whose patent expires in Italy on May 8 and in the Netherlands and Sweden on May 6. The company launched the products after obtaining necessary approvals from the regulatory authorities of the concerned countries. ? ?